INS and metabolic disease: Regarding the PO group, a significant decrease in the HOMA index was recorded, from an initial average of 4.36 to a final average of 0.94, highlighting the effectiveness of the interventions applied in improving insulin sensitivity and managing metabolic disorders within this study.